Title : Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.

Pub. Date : 2022 Jan

PMID : 34667127






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PREVENTION RELEVANCE: This study demonstrates that prophylactic treatment with the BCL2-specific antagonist venetoclax prevents breast cancer initiated by a mutated and activated PIK3CA, the most common breast oncogene. venetoclax B cell leukemia/lymphoma 2 Mus musculus